The cell cycle biomarkers: promising research, but do not oversell them
Open Access
- 24 May 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 9 (3) , 353-358
Abstract
This review focuses on the most recent scientific and clinical information on the development and clinical applicability of the cell cycle biomarkers TIMP-2 and IGFBP-7 in the diagnosis and prognosis of patients at risk for and suffering from acute kidney injury (AKI). A number of evaluation studies have demonstrated that compared with existing biomarkers, urinary excretion of the product of both biomarkers, [TIMP-2]•[IGFBP-7], improved diagnostic performance in assessing the risk for AKI, predicting the need for renal replacement therapy, AKI-related complications and short- and long-term prognoses. The reference intervals for these biomarkers, measured by the recently approved NephroCheck test, have been determined in apparently healthy adults and those with stable chronic morbid conditions without AKI. This review recognizes that the combination of these two cell cycle arrest markers for the early detection of AKI is promising but concludes that its clinical impact is still unproved. Clinicians should understand the utility and limitations of this test before deciding whether to make it available at their institution.Keywords
This publication has 59 references indexed in Scilit:
- Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patientsBMC Nephrology, 2013
- Linking Injury to Outcome in Acute Kidney Injury: A Matter of SensitivityPLOS ONE, 2013
- Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challengesClinical Kidney Journal, 2012
- Oliguria as predictive biomarker of acute kidney injury in critically ill patientsCritical Care, 2011
- Cdk2-dependent phosphorylation of p21 regulates the role of Cdk2 in cisplatin cytotoxicityAmerican Journal of Physiology-Renal Physiology, 2011
- Defining urine output criterion for acute kidney injury in critically ill patientsNephrology Dialysis Transplantation, 2010
- Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell linesMolecular Cancer Therapeutics, 2009
- The cell cycle and acute kidney injuryKidney International, 2009
- Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological ActivitiesScience Signaling, 2008
- Two faces of p53: aging and tumor suppressionNucleic Acids Research, 2007